Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (1K08DK114563-01)
American Gastroenterological Association (Research Scholars Award)
Text and Data Mining valid from 2019-11-07
Received: 25 July 2019
Accepted: 20 September 2019
First Online: 7 November 2019
Ethics approval and consent to participate
: Patient records were accessed and analyzed through a protocol approved by the Partners Institutional Review Board that waved patient consent.
: V.D. receives research support from Advanced cell Diagnostics and is a consultant for Agios. R.J.S. receives grant funding from Amgen and Merck, and consulting/advising fees from Amgen, Merck, Novartis, BMS, Array BioPharma, Replimmune, Compugen, Takeda, and Genentech, and a financial relationship with Boehringer Ingelheim. M.D. receives research funding from Novartis, and has received consulting fees from Genentech-Roche, and Tillotts Pharma. All other authors declare no competing interests.